| Year |
Citation |
Score |
| 2024 |
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, et al. Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of . Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2302474. PMID 38471061 DOI: 10.1200/JCO.23.02474 |
0.353 |
|
| 2024 |
Grunebaum E, Arnold DE, Logan B, Parikh S, Marsh RA, Griffith LM, Mallhi K, Chellapandian D, Lim SS, Deal CL, Kapoor N, Murguía-Favela L, Falcone EL, Prasad VK, Touzot F, et al. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: a PIDTC study. The Journal of Allergy and Clinical Immunology. PMID 38290608 DOI: 10.1016/j.jaci.2024.01.013 |
0.356 |
|
| 2023 |
Versluis J, Saber W, Tsai HK, Gibson CJ, Dillon LW, Mishra A, McGuirk J, Maziarz RT, Westervelt P, Hegde P, Mukherjee D, Martens MJ, Logan B, Horowitz M, Hourigan CS, et al. Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300866. PMID 37607457 DOI: 10.1200/JCO.23.00866 |
0.407 |
|
| 2023 |
Leiding JW, Arnold DE, Parikh SH, Logan BR, Marsh RA, Griffith LM, Wu R, Kidd S, Mallhi KK, Chellapandian D, Si Lim S, Grunebaum E, Falcone EL, Murguia-Favela L, Grossman D, et al. Genotype, Oxidase Status, and Preceding Infection or Autoinflammation Do Not Affect Allogeneic HCT Outcomes for CGD. Blood. PMID 37562003 DOI: 10.1182/blood.2022019586 |
0.37 |
|
| 2023 |
Logan BR, Fu D, Howard A, Fei M, Kou J, Little MR, Adom D, Mohamed FA, Blazar BR, Gafken PR, Paczesny S. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death. The Journal of Clinical Investigation. 133. PMID 37526081 DOI: 10.1172/JCI168575 |
0.358 |
|
| 2023 |
Cho C, Devlin S, Maloy M, Horowitz MM, Logan B, Rizzo JD, Giralt SA, Perales MA. Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis. Bone Marrow Transplantation. PMID 37422574 DOI: 10.1038/s41409-023-02031-2 |
0.338 |
|
| 2023 |
Thakar MS, Logan BR, Puck JM, Dunn EA, Buckley RH, Cowan MJ, O'Reilly RJ, Kapoor N, Satter LF, Pai SY, Heimall J, Chandra S, Ebens CL, Chellapandian D, Williams O, et al. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet (London, England). PMID 37352885 DOI: 10.1016/S0140-6736(23)00731-6 |
0.304 |
|
| 2023 |
Sharma A, Logan B, Estrada-Merly N, Lehmann LE, Rangarajan HG, Preussler JM, Troy JD, Akard LP, Bhatt NS, Truong TH, Wood WA, Strouse C, Juckett M, Khera N, Rizzo D, et al. Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers. Transplantation and Cellular Therapy. PMID 37220838 DOI: 10.1016/j.jtct.2023.05.013 |
0.411 |
|
| 2023 |
Jurdi NE, Martens MJ, Brunstein CG, O'Donnell P, Lee SJ, D'Souza A, Logan B, Hong S, Singh AK, Sandhu K, Shapiro RM, Horowitz MM, Hamilton BK. Heath-related Quality of Life in Double Umbilical Cord Blood vs. Haploidentical Marrow Transplantation: a QOL Analysis Report of BMT CTN 1101. Transplantation and Cellular Therapy. PMID 37088401 DOI: 10.1016/j.jtct.2023.04.009 |
0.398 |
|
| 2023 |
Devine SM, Bo-Subait S, Kuxhausen M, Spellman SR, Bupp C, Ahn KW, Stefanski HE, Auletta JJ, Logan BR, Shaw BE. Clinical Impact of Cryopreservation of Allogeneic Hematopoietic Cell Grafts During the Onset of the COVID-19 Pandemic. Blood Advances. PMID 37036959 DOI: 10.1182/bloodadvances.2023009786 |
0.407 |
|
| 2023 |
Guru Murthy GS, Logan BR, Bo-Subait S, Beitinjaneh A, Devine S, Farhadfar N, Gowda L, Hashmi S, Lazarus H, Nathan S, Sharma A, Yared JA, Stefanski HE, Pulsipher MA, Hsu JW, et al. Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia. American Journal of Hematology. PMID 36606713 DOI: 10.1002/ajh.26834 |
0.44 |
|
| 2022 |
Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, et al. Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplant cyclophosphamide: follow-up from a National Marrow Donor Program-sponsored prospective clinical trial. Transplantation and Cellular Therapy. PMID 36584941 DOI: 10.1016/j.jtct.2022.12.017 |
0.438 |
|
| 2022 |
Friend B, Broglie L, Logan BR, Chhabra S, Bupp C, Schiller G, Beitinjaneh A, Perez MAD, Guilcher GMT, Hashem H, Hildebrandt GC, Krem MM, Lazarus HM, Nishihori T, Nusrat R, et al. Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. PMID 36442769 DOI: 10.1016/j.jtct.2022.11.019 |
0.345 |
|
| 2022 |
Cusatis R, Martens MJ, Nakamura R, Cutler CS, Saber W, Lee SJ, Logan BR, Shaw BE, Gregory A, D'Souza A, Hamilton BK, Horowitz MM, Flynn KE. Health-related quality of life in reduced intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102. American Journal of Hematology. PMID 36251401 DOI: 10.1002/ajh.26768 |
0.385 |
|
| 2022 |
Labrosse R, Boufaied I, Bourdin B, Gona S, Randolph HE, Logan BR, Bourbonnais S, Berthe C, Chan W, Buckley RH, Parrott RE, Cuvelier GDE, Kapoor N, Chandra S, Dávila Saldaña BJ, et al. Aberrant T-cell exhaustion in SCID survivors with poor T-cell reconstitution post transplant. The Journal of Allergy and Clinical Immunology. PMID 35987350 DOI: 10.1016/j.jaci.2022.08.004 |
0.32 |
|
| 2022 |
DeZern AE, Eapen M, Wu J, Talano JA, Solh M, Dávila Saldaña BJ, Karanes C, Horwitz ME, Mallhi K, Arai S, Farhadfar N, Hexner E, Westervelt P, Antin JH, Deeg HJ, ... ... Logan BR, et al. Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial. The Lancet. Haematology. PMID 35907408 DOI: 10.1016/S2352-3026(22)00206-X |
0.364 |
|
| 2022 |
Cuvelier GDE, Logan BR, Prockop S, Buckley RH, Kuo CY, Griffith LM, Liu X, Yip A, Hershfield M, Ayoub P, Moore TB, Dorsey M, O'Reilly RJ, Kapoor N, Pai SY, et al. Outcomes Following Treatment for Adenosine Deaminase Deficient Severe Combined Immunodeficiency: A Report from the PIDTC. Blood. PMID 35671392 DOI: 10.1182/blood.2022016196 |
0.341 |
|
| 2022 |
Broglie L, Friend BD, Chhabra S, Bupp C, Schiller GJ, Logan B, Pasquini MC, Savani B, Stadtmauer EA, Thakar MS, Sorror M. Differential use of the hematopoietic cell transplantation-comorbidity index among adult and pediatric transplant physicians. Leukemia & Lymphoma. 1-4. PMID 35583292 DOI: 10.1080/10428194.2022.2076848 |
0.348 |
|
| 2022 |
Brunstein CG, O'Donnell PV, Logan B, Dawson P, Costa L, Cutler C, Craig M, Hogan W, M Horowitz M, Horwitz ME, Karanes C, Magenau JM, Malone A, McCarty J, McGuirk JP, et al. Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis BMT CTN 1101Open for Accrual June 2012Open for Accrual June 2012. Transplantation and Cellular Therapy. PMID 35390529 DOI: 10.1016/j.jtct.2022.03.024 |
0.442 |
|
| 2021 |
Luznik L, Pasquini MC, Logan B, Soiffer RJ, Wu J, Devine SM, Geller N, Giralt S, Heslop HE, Horowitz MM, Jones RJ, Litzow MR, Mendizabal A, Muffly L, Nemecek ER, et al. Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102293. PMID 34855460 DOI: 10.1200/JCO.21.02293 |
0.402 |
|
| 2021 |
Nakamura R, Saber W, Martens MJ, Ramirez A, Scott B, Oran B, Leifer E, Tamari R, Mishra A, Maziarz RT, McGuirk J, Westervelt P, Vasu S, Patnaik M, Kamble R, ... ... Logan B, et al. Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2003380. PMID 34106753 DOI: 10.1200/JCO.20.03380 |
0.372 |
|
| 2021 |
Dillon LW, Gui G, Logan BR, Fei M, Ghannam J, Li Y, Licon A, Alyea EP, Bashey A, Devine SM, Fernandez HF, Giralt S, Hamadani M, Howard A, Maziarz RT, et al. Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome. Jco Precision Oncology. 5. PMID 34036237 DOI: 10.1200/PO.20.00355 |
0.339 |
|
| 2021 |
Kim HT, Logan B, Weisdorf DJ. Novel Composite Endpoints after Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. PMID 34004355 DOI: 10.1016/j.jtct.2021.05.005 |
0.315 |
|
| 2021 |
Logan BR, Maiers MJ, Sparapani RA, Laud PW, Spellman SR, McCulloch RE, Shaw BE. Optimal Donor Selection for Hematopoietic Cell Transplantation Using Bayesian Machine Learning. Jco Clinical Cancer Informatics. 5: 494-507. PMID 33950708 DOI: 10.1200/CCI.20.00185 |
0.315 |
|
| 2021 |
Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, et al. National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2003502. PMID 33905264 DOI: 10.1200/JCO.20.03502 |
0.411 |
|
| 2021 |
Wingard JR, Ahn KW, Dandoy C, Perales MA, Wood WA, Logan B, Riches M, Rizzo JD. COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes Forum. Transplantation and Cellular Therapy. 27: 533-539. PMID 33895401 DOI: 10.1016/j.jtct.2021.04.008 |
0.393 |
|
| 2021 |
Hsu JW, Farhadfar N, Murthy H, Logan BR, Bo-Subait S, Frey N, Goldstein SC, Horowitz MM, Lazarus H, Schwanke JD, Shah NN, Spellman SR, Switzer GE, Devine SM, Shaw BE, et al. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic. Transplantation and Cellular Therapy. PMID 33865804 DOI: 10.1016/j.jtct.2021.03.015 |
0.428 |
|
| 2021 |
Seftel MD, Chitphakdithai P, Miller JP, Kobusingye H, Logan BR, Linenberger M, Artz AS, Haight AE, Jacobsohn DA, Litzow MR, Magalhaes-Silverman M, Selby GB, Vusirikala M, Horowitz MM, Switzer GE, et al. Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study. Transplantation and Cellular Therapy. 27: 352.e1-352.e5. PMID 33836890 DOI: 10.1016/j.jtct.2021.01.009 |
0.369 |
|
| 2021 |
Panch SR, Logan B, Sees JA, Bo-Subait S, Savani B, Shah NN, Hsu JW, Switzer G, Lazarus HM, Anderlini P, Hematti P, Confer D, Pulsipher MA, Shaw BE, Stroncek DF. Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations. Transplantation and Cellular Therapy. PMID 33823169 DOI: 10.1016/j.jtct.2021.03.008 |
0.331 |
|
| 2021 |
Fuchs EJ, O'Donnell PV, Eapen M, Logan B, Antin JH, Dawson P, Devine S, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, et al. Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. Blood. 137: 420-428. PMID 33475736 DOI: 10.1182/blood.2020007535 |
0.454 |
|
| 2020 |
Kim S, Logan B, Riches M, Chen M, Ahn KW. Tatistical methods for time-dependent variables in hematopoietic cell transplantation studies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 33017663 DOI: 10.1016/j.bbmt.2020.09.034 |
0.353 |
|
| 2020 |
Fuchs EJ, O'Donnell PV, Eapen M, Logan BR, Antin JH, Dawson P, Devine SM, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, et al. Double unrelated umbilical cord blood versus HLA-haploidentical bone marrow transplantation (BMT CTN 1101). Blood. PMID 32870242 DOI: 10.1182/Blood.2020007535 |
0.529 |
|
| 2020 |
Farhadfar N, Murthy HS, Logan BR, Sees JA, Mouhab A, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, et al. Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. Bone Marrow Transplantation. PMID 32355289 DOI: 10.1038/S41409-020-0911-8 |
0.427 |
|
| 2020 |
Burroughs L, Petrovic A, Brazauskas R, Liu X, Griffith LM, Ochs HD, Bleesing J, Edwards S, Dvorak CC, Chaudhury S, Prockop S, Quinones R, Goldman F, Quigg T, Chandrakasan S, ... ... Logan BR, et al. Excellent Outcomes Following Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: A PIDTC Report. Blood. PMID 32268350 DOI: 10.1182/Blood.2019002939 |
0.483 |
|
| 2020 |
Chan AY, Leiding JW, Liu X, Logan BR, Burroughs LM, Allenspach EJ, Skoda-Smith S, Uzel G, Notarangelo LD, Slatter M, Gennery AR, Smith AR, Pai SY, Jordan MB, Marsh RA, et al. Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey. Frontiers in Immunology. 11: 239. PMID 32153572 DOI: 10.3389/Fimmu.2020.00239 |
0.427 |
|
| 2020 |
Seftel MD, Kuxhausen M, Burns L, Chitphakdithai P, Confer D, Kiefer D, Lee S, Logan B, O'Donnell P, Pulsipher M, Shah NN, Switzer G, Shaw BE. CLONAL HEMATOPOIESIS IN RELATED ALLOGENEIC TRANSPLANT DONORS: IMPLICATIONS FOR SCREENING AND MANAGEMENT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32147534 DOI: 10.1016/J.Bbmt.2020.02.022 |
0.421 |
|
| 2020 |
Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, Chee L, Copelan E, Freytes CO, Hematti P, Lazarus HM, Litzow M, Nishihori T, Olsson RF, Prestidge T, et al. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy. British Journal of Haematology. PMID 32124435 DOI: 10.1111/Bjh.16457 |
0.514 |
|
| 2020 |
Farhadfar N, Hsu JW, Logan BR, Sees JA, Chitphakdithai P, Sugrue MW, Abdel-Azim H, Anderlini PN, Bredeson C, Chhabra S, Diaz MA, Ganguly S, Hematti P, Kamble RT, Kasow KA, et al. Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield. Blood Advances. 4: 706-716. PMID 32092138 DOI: 10.1182/BLOODADVANCES.2019000923 |
0.362 |
|
| 2020 |
Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredseon C, Chhabra S, Dandoy CE, et al. Collection of Peripheral Blood Progenitor Cells in One Day is Associated with Decreased Donor Toxicity compared to Two Days in Unrelated Donors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32088366 DOI: 10.1016/J.Bbmt.2020.02.011 |
0.365 |
|
| 2020 |
Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW. Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. Blood Advances. 4: 467-476. PMID 32027744 DOI: 10.1182/Bloodadvances.2019000765 |
0.412 |
|
| 2020 |
Thakar MS, Browning M, Hari P, Charlson JA, Margolis DA, Logan B, Schloemer N, Kelly ME, Newman A, Johnson B, Keever-Taylor CA, Malarkannan S. Phase II trial using haploidentical hematopoietic cell transplantation (HCT) followed by donor natural killer (NK) cell infusion and sirolimus maintenance for patients with high-risk solid tumors. Journal of Clinical Oncology. 38: e23551-e23551. DOI: 10.1200/Jco.2020.38.15_Suppl.E23551 |
0.508 |
|
| 2020 |
Farhadfar N, Murthy H, Wang T, Fretham C, Dias A, Logan B, Mineishi S, Savani B, Stadtmauer EA, Chhabra S, Ganguly S, Wingard JR, Pasquini MC. Development of the Renal Adjusted Hematopoietic Cell Transplant Comorbidity Index (RA-HCT-CI) Using Different Levels of Renal Dysfunction According to Estimated Glomerular Filtration Rate (eGFR) Biology of Blood and Marrow Transplantation. 26: S134-S135. DOI: 10.1016/J.Bbmt.2019.12.657 |
0.324 |
|
| 2020 |
Shaw BE, Burns LJ, Logan B, Jimenez-Jimenez AM, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang X, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, et al. Transplantation Using Bone Marrow from a (very) HLA Mismatched Unrelated Donor in the Setting of Post-Transplant Cyclophosphamide Is Feasible and Expands Access to Underserved Minorities Biology of Blood and Marrow Transplantation. 26: S283-S284. DOI: 10.1016/J.Bbmt.2019.12.553 |
0.535 |
|
| 2020 |
Avigan DE, Shah N, Logan B, Zhu J, Bisharat L, Callander NS, Chodon T, Dhakal B, Efebera YA, Geller N, Hematti P, Herman M, Lazarus HM, McKenna DH, Nelson C, et al. Evaluation of Tumor Vaccine Generation in a Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant (AutoHCT)Followed By Lenalidomide Maintenance for Multiple Myeloma (MM) with or without Vaccination with Dendritic Cell/ Myeloma Fusions (DC/MM fusion vaccine): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1401 Biology of Blood and Marrow Transplantation. 26: S62-S63. DOI: 10.1016/J.Bbmt.2019.12.230 |
0.302 |
|
| 2020 |
Vasu S, Bejanyan N, Devine SM, Hexner E, Krakow E, Logan B, Luznik L, Ragon B, Barrett E, Shan J, Champlin RE. BMT CTN 1803: Trial to Investigate If Haploidentical Natural Killer Cells (CSTD002) Prevent Post-Transplant Relapse in AML and MDS (NK-REALM) Biology of Blood and Marrow Transplantation. 26: S371-S372. DOI: 10.1016/J.Bbmt.2019.12.174 |
0.513 |
|
| 2020 |
Thakar MS, Logan B, Buckley RH, Haddad E, Dvorak CC, O'Reilly RJ, Kapoor N, Satter LF, Martinez C, Pai S, Heimall J, Jyonouchi S, Sullivan KE, Chandra S, Smith AR, et al. Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC) Biology of Blood and Marrow Transplantation. 26: S18-S19. DOI: 10.1016/J.Bbmt.2019.12.083 |
0.45 |
|
| 2019 |
Hourigan CS, Dillon LW, Gui G, Logan BR, Fei M, Ghannam J, Li Y, Licon A, Alyea EP, Bashey A, Deeg HJ, Devine SM, Fernandez HF, Giralt S, Hamadani M, et al. Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1903011. PMID 31860405 DOI: 10.1200/Jco.19.03011 |
0.478 |
|
| 2019 |
Atallah E, Logan B, Chen M, Cutler C, Deeg J, Jacoby M, Champlin R, Nishihori T, Confer D, Gajewski J, Farnia S, Greenberg P, Warlick E, Weisdorf D, Saber W, et al. Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study. Jama Oncology. PMID 31830234 DOI: 10.1001/Jamaoncol.2019.5140 |
0.443 |
|
| 2019 |
Knight JM, Rizzo JD, Wang T, He N, Logan BR, Spellman SR, Lee SJ, Verneris MR, Arevalo JMG, Cole SW. Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia. Jnci Cancer Spectrum. 3: pkz073. PMID 31763620 DOI: 10.1093/Jncics/Pkz073 |
0.437 |
|
| 2019 |
Ballen K, Logan BR, Chitphakdithai P, Kuxhausen M, Spellman SR, Adams A, Drexler RJ, Duffy M, Kemp A, King R, Babic A, Delaney C, Karanes C, Kurtzberg J, Petz L, et al. Unlicensed umbilical cord blood units provide a safe and effective graft source for a diverse population: A study of 2456 umbilical cord blood recipients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31756539 DOI: 10.1016/J.Bbmt.2019.11.016 |
0.438 |
|
| 2019 |
Giralt S, Costa LJ, Maloney D, Krishnan A, Fei M, Antin JH, Brunstein C, Geller N, Goodman S, Hari P, Logan B, Lowsky R, Qazilbash MH, Sahebi F, Somlo G, et al. Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma: Long-term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31756536 DOI: 10.1016/J.Bbmt.2019.11.018 |
0.489 |
|
| 2019 |
Majhail NS, Mau LW, Chitphakdithai P, Denzen EM, Joffe S, Lee SJ, LeMaistre CF, Loberiza F, Parsons SK, Repaczki-Jones R, Robinett P, Douglas Rizzo J, Murphy E, Logan B, Le-Rademacher J. Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. Bone Marrow Transplantation. PMID 31740767 DOI: 10.1038/S41409-019-0748-1 |
0.489 |
|
| 2019 |
Pidala J, Hamadani M, Dawson P, Martens M, Alousi AM, Jagasia M, Efebera YA, Chhabra S, Pusic I, Holtan SG, Ferrara JL, Levine JE, Mielcarek M, Anasetti C, Antin JH, ... ... Logan BR, et al. Randomized Multicenter Trial of Sirolimus vs. Prednisone as Initial Therapy for Standard Risk Acute GVHD: BMT CTN 1501. Blood. PMID 31738834 DOI: 10.1182/Blood.2019003125 |
0.453 |
|
| 2019 |
Martens MJ, Logan BR. Group sequential tests for treatment effect on survival and cumulative incidence at a fixed time point. Lifetime Data Analysis. PMID 31729633 DOI: 10.1007/S10985-019-09491-Z |
0.415 |
|
| 2019 |
Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, et al. Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31563573 DOI: 10.1016/J.Bbmt.2019.09.027 |
0.468 |
|
| 2019 |
Pidala J, Martens M, Anasetti C, Carreras J, Horowitz M, Lee SJ, Antin J, Cutler C, Logan B. Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation. Jama Oncology. PMID 31556923 DOI: 10.1001/Jamaoncol.2019.2974 |
0.434 |
|
| 2019 |
Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, et al. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. Journal of Clinical Immunology. PMID 31376032 DOI: 10.1007/S10875-019-00659-8 |
0.427 |
|
| 2019 |
Waller EK, Logan BR, Fei M, Lee SJ, Confer D, Howard A, Chandrakasan S, Anasetti C, Fernando SM, Giver CR. Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation. Blood Advances. 3: 2250-2263. PMID 31345792 DOI: 10.1182/Bloodadvances.2018029892 |
0.438 |
|
| 2019 |
Ambinder RF, Wu J, Logan B, Durand CM, Shields R, Popat UR, Little RF, McMahon DK, Cyktor J, Mellors JW, Ayala E, Kaplan LD, Noy A, Jones RJ, Howard A, et al. Allogeneic hematopoietic cell transplant for HIV patients with hematologic malignancies: the BMT CTN-0903/AMC-080 trial. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31279752 DOI: 10.1016/J.Bbmt.2019.06.033 |
0.506 |
|
| 2019 |
Hurley CK, Spellman S, Dehn J, Barker JN, Devine S, Fernandez-Vina M, Gautreaux M, Logan B, Maiers M, Mueller C, Perales MA, Yu N, Pidala J. Letter to the Editor regarding "Recipients receiving better HLA-matched hematopoietic cell transplantation grafts, uncovered by a novel HLA typing method, have superior survival: A retrospective study": 2019 May 2 Letter to the Editor Biology of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31145991 DOI: 10.1016/J.Bbmt.2019.05.026 |
0.511 |
|
| 2019 |
Wiener L, Hoag JA, Pelletier W, Shah NN, Shaw BE, Pulsipher MA, Bruce J, Bader P, Willasch AM, Dalissier A, Guilcher G, Anthias C, Confer DL, Sees JA, Logan B, et al. Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donors. Bone Marrow Transplantation. PMID 30971776 DOI: 10.1038/S41409-019-0515-3 |
0.426 |
|
| 2019 |
Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, ... ... Logan BR, et al. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). The Lancet. Haematology. 6: e132-e143. PMID 30824040 DOI: 10.1016/S2352-3026(18)30221-7 |
0.503 |
|
| 2019 |
Liu N, Liu Y, Logan B, Xu Z, Tang J, Wang Y. Learning the Dynamic Treatment Regimes from Medical Registry Data through Deep Q-network. Scientific Reports. 9: 1495. PMID 30728403 DOI: 10.1038/S41598-018-37142-0 |
0.323 |
|
| 2019 |
Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, et al. The concentration of total nucleated cells in harvested bone marrow for transplantation has decreased over time. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30716454 DOI: 10.1016/J.Bbmt.2019.01.034 |
0.491 |
|
| 2019 |
Sparapani R, Logan BR, McCulloch RE, Laud PW. Nonparametric competing risks analysis using Bayesian Additive Regression Trees. Statistical Methods in Medical Research. 962280218822140. PMID 30612519 DOI: 10.1177/0962280218822140 |
0.354 |
|
| 2019 |
Vasu S, Bejanyan N, Devine S, Krakow E, Krakow E, Logan B, Luznik L, Ragon BK, Barrett E, Shan J, Champlin RE. BMT CTN 1803: Haploidentical Natural Killer Cells (CSTD002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM) Blood. 134: 1955-1955. DOI: 10.1182/Blood-2019-128005 |
0.522 |
|
| 2019 |
Farhadfar N, Dias AL, Wang T, Fretham C, Murthy HS, Logan BR, Mineishi S, Savani BN, Stadtmauer EA, Chhabra S, Wingard JR, Ganguly S, Pasquini MC. Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT) Blood. 134: 3256-3256. DOI: 10.1182/Blood-2019-125761 |
0.423 |
|
| 2019 |
Levis MJ, Hamadani M, Logan BR, Rosales M, Delgado D, Bahceci E, Devine S, Horowitz MM, Chen Y. BMT CTN Protocol 1506: A Phase 3 Trial of Gilteritinib As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with FLT3-ITD+ AML Blood. 134: 4602-4602. DOI: 10.1182/Blood-2019-124322 |
0.371 |
|
| 2019 |
Panch SR, Logan BR, Sees JA, Savani BN, Shah NN, Hsu JW, Pulsipher MA, Switzer GE, Shaw BE, Stroncek DF. Lower Hematopoietic Progenitor Cell Counts and Yields at Subsequent Donations Is Influenced By a Shorter Inter-Donation Interval between the First and Subsequent Mobilizations Blood. 134: 1962-1962. DOI: 10.1182/Blood-2019-123492 |
0.412 |
|
| 2019 |
Holtan S, Bhatt AS, Fraser R, Perales M, Kean L, Saber W, Hamadani M, Logan BR, Bolaños-Meade J. Making Progress in Graft-Versus-Host Disease Prophylaxis and Microbiome Analysis in the Blood and Marrow Transplant Clinical Trials Network: Progress III (1703)/MI-Immune (1801) Blood. 134: 2005-2005. DOI: 10.1182/Blood-2019-122782 |
0.438 |
|
| 2019 |
Hsu JW, Kim S, Logan BR, Sees JA, Chitphakdithai P, Confer DL, Pulsipher MA, Shah NN, Switzer GE, Shaw BE, Wingard JR. Peripheral Blood Stem Cell Collection in One Day Is Preferable to Two Days in Unrelated Donors Biology of Blood and Marrow Transplantation. 25: S199-S200. DOI: 10.1016/J.Bbmt.2018.12.334 |
0.353 |
|
| 2019 |
Farhadfar N, Murthy H, Khanal M, Ahn KW, Logan BR, Sees JA, Chitphakdithai P, Confer DL, Pulsipher MA, Shah NN, Switzer GE, Shaw BE, Wingard JR. Impact of Autologous Blood Transfusion after Bone Marrow Harvest on Donor Health and Outcome Biology of Blood and Marrow Transplantation. 25: S198-S199. DOI: 10.1016/J.Bbmt.2018.12.333 |
0.402 |
|
| 2019 |
Ballen KK, Logan BR, Kuxhausen M, Chitphakdithai P, Spellman SR, Adams AJ, Drexler RJ, Duffy M, Kemp A, King RJ, Babic A, Delaney C, Karanes C, Kurtzberg J, Petz L, et al. Use of Unlicensed Unrelated Umbilical Cord Blood Expands Access to Underserved Patients: Report of 2466 Transplants in a Racially/Ethnically Diverse Population Biology of Blood and Marrow Transplantation. 25: S221-S222. DOI: 10.1016/J.Bbmt.2018.12.305 |
0.451 |
|
| 2019 |
Knight J, Rizzo JD, Wang T, He N, Logan BR, Spellman SR, Lee SJ, Verneris MR, Arevalo JM, Cole SW. Abstract # 3208 Molecular correlates of socioeconomic status predict acute myelogenous leukemia relapse following hematopoietic cell transplantation Brain Behavior and Immunity. 81: 1-2. DOI: 10.1016/J.Bbi.2019.08.012 |
0.44 |
|
| 2019 |
Knight JM, Rizzo JD, Hari P, Giles KE, Pasquini MC, D’Souza A, Logan BR, Hamadani M, Chhabra S, Dhaka B, Shah N, Cole SW. Abstract # 2055 Beta-adrenergic blockade inhibits stress-related transcriptome profiles associated with worse cancer outcomes: A randomized controlled study of propranolol in hematopoietic cell transplantation recipients Brain Behavior and Immunity. 76. DOI: 10.1016/J.Bbi.2018.11.183 |
0.447 |
|
| 2018 |
Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, et al. Higher risks of toxicity and incomplete recovery in 13-17 year old females after marrow donation: RDSafe peds results. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30605731 DOI: 10.1016/J.Bbmt.2018.12.765 |
0.318 |
|
| 2018 |
Thakar M, Broglie L, Logan B, Artz A, Bunin N, Burroughs LM, Fretham C, Jacobsohn DA, Loren AW, Kurtzberg J, Martinez CA, Mineishi S, Nelson AS, Woolfrey A, Pasquini MC, et al. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for non-malignant diseases. Blood. PMID 30545834 DOI: 10.1182/Blood-2018-09-876284 |
0.471 |
|
| 2018 |
Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, et al. The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30423480 DOI: 10.1016/J.Bbmt.2018.11.004 |
0.384 |
|
| 2018 |
Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, et al. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors. Haematologica. PMID 30381298 DOI: 10.3324/Haematol.2018.200121 |
0.466 |
|
| 2018 |
Mangurian C, Scalchunes C, Yoo J, Logan B, Henderson T, Iyengar S, Smith H, Cowan MJ. Psychosocial services for primary immunodeficiency disorder families during hematopoietic cell transplantation: A descriptive study. Palliative & Supportive Care. 1-6. PMID 30223912 DOI: 10.1017/S1478951518000603 |
0.394 |
|
| 2018 |
Haddad E, Logan BR, Griffith LM, Buckley RH, Parrot RE, Prockop SE, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing JJH, et al. SCID genotype and 6-month post-transplant CD4 count predict survival and immune recovery: a PIDTC retrospective study. Blood. PMID 30154114 DOI: 10.1182/Blood-2018-03-840702 |
0.47 |
|
| 2018 |
Wang Y, Logan BR. Testing for center effects on survival and competing risks outcomes using pseudo-value regression. Lifetime Data Analysis. PMID 29978275 DOI: 10.1007/S10985-018-9443-6 |
0.366 |
|
| 2018 |
Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, et al. A phase II/III randomized, multicenter trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for treatment of chronic graft-versus-host disease: BMT CTN 0801. Haematologica. PMID 29954931 DOI: 10.3324/Haematol.2018.195123 |
0.373 |
|
| 2018 |
Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, et al. Outcomes of measurable residual disease in pediatric acute myeloid leukemia pre- and post-hematopoietic stem cell transplant: validation of difference from normal flow cytometry with chimerism studies and Wilms tumor 1 gene expression. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29933069 DOI: 10.1016/J.Bbmt.2018.06.010 |
0.453 |
|
| 2018 |
Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, et al. Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. Bmc Cancer. 18: 593. PMID 29793446 DOI: 10.1186/S12885-018-4509-0 |
0.45 |
|
| 2018 |
Moodie EEM, Stephens DA, Alam S, Zhang MJ, Logan B, Arora M, Spellman S, Krakow EF. A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients. Biometrical Journal. Biometrische Zeitschrift. PMID 29766558 DOI: 10.1002/Bimj.201700181 |
0.461 |
|
| 2018 |
Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Dávila Saldaña BJ, Eibel H, Hopkins G, et al. B cell differentiation and IL-21 response in / SCID patients after hematopoietic stem cell transplantation. Blood. PMID 29728406 DOI: 10.1182/Blood-2017-10-809822 |
0.378 |
|
| 2018 |
Martens MJ, Logan BR. A group sequential test for treatment effect based on the Fine-Gray model. Biometrics. PMID 29534294 DOI: 10.1111/Biom.12871 |
0.38 |
|
| 2018 |
Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, et al. Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29454040 DOI: 10.1016/J.Bbmt.2018.02.006 |
0.488 |
|
| 2018 |
Pasquini MC, Logan B, Jones RJ, Alousi AM, Appelbaum FR, Bolaños-Meade J, Flowers MED, Giralt S, Horowitz MM, Jacobsohn D, Koreth J, Levine JE, Luznik L, Maziarz R, Mendizabal A, et al. Blood and Marrow Transplant Clinical Trials Network Report on Development of Novel Endpoints and Selection of Promising Approaches for Graft-Versus-Host Disease Prevention Trials. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29325830 DOI: 10.1016/J.Bbmt.2018.01.002 |
0.463 |
|
| 2018 |
Levis MJ, Hamadani M, Logan B, Rosales M, Perl AE, Devine SM, Bahceci E, Chen YA. A phase 3, trial of gilteritinib, as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with FLT3-ITD+ AML. Journal of Clinical Oncology. 36: TPS7075-TPS7075. DOI: 10.1200/Jco.2018.36.15_Suppl.Tps7075 |
0.413 |
|
| 2018 |
Leiding JW, Logan BR, Yin Z, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs L, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GD, Thakar M, Chen K, et al. Resolution of CGD Related Colitis after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Granulomatous Disease—Early Results From the 6903 Study of the Primary Immune Deficiency Treatment Consortium (PIDTC) Biology of Blood and Marrow Transplantation. 24: S80-S81. DOI: 10.1016/J.Bbmt.2017.12.624 |
0.445 |
|
| 2018 |
Brogile L, Thakar M, Logan BR, Artz A, Jacobsohn DA, Bunin NJ, Burroughs L, Martinez C, Nelson AS, Woolfrey AE, Pasquini MC, Sorror ML. Evaluation of the Hematopoietic Cell Comorbidity Index (HCT-CI) in Recipients of Allogeneic Transplantation for Non-Malignant Biology of Blood and Marrow Transplantation. 24: S38. DOI: 10.1016/J.Bbmt.2017.12.590 |
0.479 |
|
| 2018 |
Knight J, Rizzo JD, Wang T, He N, Logan BR, Spellman SR, Lee SJ, Cole S. Genomic Mechanisms of SES-Related Outcome Disparities in Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 24: S26. DOI: 10.1016/J.Bbmt.2017.12.581 |
0.413 |
|
| 2018 |
Knight J, Rizzo JD, Hari P, Kerswill S, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Cole S. Propranolol Inhibits Stress-Related Gene Expression Profiles Associated with Adverse Clinical Outcomes in Autologous Hematopoietic Cell Transplantation Recipients Biology of Blood and Marrow Transplantation. 24: S253-S254. DOI: 10.1016/J.Bbmt.2017.12.183 |
0.422 |
|
| 2018 |
Zinter MS, Logan BR, Zhu X, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Fretham C, Gale RP, Guinan E, et al. Improved Mortality Prognostication for Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results From a Virtual Pediatric Systems (VPS) and Center for International Blood and Marrow Transplant Research (CIBMTR) Database Merger Biology of Blood and Marrow Transplantation. 24: S117-S119. DOI: 10.1016/J.Bbmt.2017.12.034 |
0.49 |
|
| 2018 |
Ballen K, Logan BR, Chitphakdithai P, Spellman SR, Adams A, Drexler RJ, Duffy M, Kemp A, King R, Babic A, Delaney C, Karanes C, Kurtzberg J, Petz L, Scaradavou A, et al. Excellent Outcomes After Umbilical Cord Blood Transplantation Using a Centralized Cord Blood Registry Stem Cells Translational Medicine. 7: S1-S1. DOI: 10.1002/Sctm.12353 |
0.365 |
|
| 2017 |
Logan BR, Sparapani R, McCulloch RE, Laud PW. Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees. Statistical Methods in Medical Research. 962280217746191. PMID 29254443 DOI: 10.1177/0962280217746191 |
0.314 |
|
| 2017 |
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Pulsipher MA, Parikh S, Martinez C, Kapoor N, O'Reilly R, Boyer M, Pai SY, Goldman F, et al. Immune Reconstitution and Survival of 100 SCID Patients Post Hematopoietic Cell Transplant: A PIDTC Natural History Study. Blood. PMID 29021228 DOI: 10.1182/Blood-2017-05-781849 |
0.449 |
|
| 2017 |
Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, et al. Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields are Less. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28958894 DOI: 10.1016/J.Bbmt.2017.09.013 |
0.435 |
|
| 2017 |
Krakow EF, Hemmer M, Wang T, Logan B, Arora M, Spellman S, Couriel D, Alousi A, Pidala J, Last M, Lachance S, Moodie EEM. Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning. American Journal of Epidemiology. PMID 28472335 DOI: 10.1093/Aje/Kwx027 |
0.415 |
|
| 2017 |
Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, et al. Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 35: 1154-1161. PMID 28380315 DOI: 10.1200/Jco.2016.70.7091 |
0.461 |
|
| 2017 |
Ambinder RF, Wu J, Logan B, Durand C, Shields R, Popat UR, Little RF, Mcmahon D, Mellors JW, Ayala E, Kaplan LD, Noy A, Howard A, Forman SJ, Mendizabal AM, et al. Allogeneic hematopoietic cell transplant (alloHCT) for hematologic malignancies in human immunodeficiency virus infected (HIV) patients (pts): Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0903)/AIDS Malignancy Consortium (AMC-080) trial. Journal of Clinical Oncology. 35: 7006-7006. DOI: 10.1200/Jco.2017.35.15_Suppl.7006 |
0.368 |
|
| 2017 |
Shaw BE, Logan BR, Spellman SR, Marsh SG, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter DL, Petersdorf EW, Woolfrey A, et al. Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival Blood. 130: 848-848. DOI: 10.1182/Blood.V130.Suppl_1.848.848 |
0.477 |
|
| 2017 |
Fernando SM, Logan BR, Fei M, Lee SJ, Confer D, Howard A, Chandrakasan S, Giver CR, Anasetti C, Waller EK. Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201 Blood. 130: 516-516. DOI: 10.1182/Blood.V130.Suppl_1.516.516 |
0.445 |
|
| 2017 |
Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Puck J, Prockop SE, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing J, Chandra S, Smith AR, et al. Genotype, Phenotype and T Cell Counts at One Year Predict Survival and Long Term Immune Reconstitution after Transplantation in Severe Combined Immune Deficiency (SCID)—The Primary Immune Deficiency Treatment Consortium (PIDTC) Biology of Blood and Marrow Transplantation. 23: S133-S134. DOI: 10.1016/J.Bbmt.2017.01.052 |
0.354 |
|
| 2017 |
Ballen KK, Logan BR, Chitphakdithai P, Spellman S, Adams AJ, Drexler RJ, Duffy M, Kemp A, King RJ, Delaney C, Shpall EJ, Kurtzberg J, Babic A, Confer DL, Miller JP. Excellent Outcomes in 1589 Patients Receiving Umbilical Cord Blood Transplantation Using Unlicensed Units From a Centralized Cord Blood Registry Biology of Blood and Marrow Transplantation. 23: S170. DOI: 10.1016/J.Bbmt.2016.12.282 |
0.385 |
|
| 2017 |
Knight JM, Rizzo JD, Hari P, Pasquini MP, Kerswill S, d’Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Horowitz MM, Cole SW. Feasibility of a randomized controlled pilot study using propranolol to decrease beta-adrenergic signaling in hematopoietic stem cell transplant recipients Brain Behavior and Immunity. 66. DOI: 10.1016/J.Bbi.2017.07.021 |
0.367 |
|
| 2016 |
Ahn KW, Logan BR. PSEUDO-VALUE APPROACH FOR CONDITIONAL QUANTILE RESIDUAL LIFETIME ANALYSIS FOR CLUSTERED SURVIVAL AND COMPETING RISKS DATA WITH APPLICATIONS TO BONE MARROW TRANSPLANT DATA. The Annals of Applied Statistics. 10: 618-637. PMID 29081872 DOI: 10.1214/16-Aoas927 |
0.348 |
|
| 2016 |
Abu Zaid M, Wu J, Wu C, Logan BR, Yu J, Cutler C, Antin JH, Paczesny S, Choi SW. Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT. Blood. PMID 27827824 DOI: 10.1182/Blood-2016-08-735324 |
0.489 |
|
| 2016 |
Wingard JR, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight JM, Jacobsen PB, Jim H, Majhail NS, Syrjala K, Rizzo JD, Lee SJ. Pre-Transplant Exercise and Hematopoietic Cell Transplant Survival: a Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27742574 DOI: 10.1016/J.Bbmt.2016.10.007 |
0.454 |
|
| 2016 |
Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, Lazarus HM, Litzow M, Loren A, Majhail NS, Maziarz RT, McCarthy P, Popat U, Saber W, Spellman S, et al. The prognostic value of serum c-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. Haematologica. PMID 27662010 DOI: 10.3324/Haematol.2016.145847 |
0.486 |
|
| 2016 |
Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, et al. A BMT CTN phase II trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood. PMID 27625358 DOI: 10.1182/Blood-2016-05-715870 |
0.492 |
|
| 2016 |
Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HS, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, et al. Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes Following Hematopoietic Stem Cell Transplantation: a Study From the BMT CTN 0902 Trial. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27565521 DOI: 10.1016/J.Bbmt.2016.08.016 |
0.489 |
|
| 2016 |
Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C. Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. Jama Oncology. PMID 27532508 DOI: 10.1001/Jamaoncol.2016.2520 |
0.507 |
|
| 2016 |
O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers ME, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, et al. Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. Bone Marrow Transplantation. PMID 27526284 DOI: 10.1038/Bmt.2016.215 |
0.553 |
|
| 2016 |
Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, et al. A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. PMID 27427921 DOI: 10.1038/Bmt.2016.188 |
0.543 |
|
| 2016 |
D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin J, Howard A, Goodman S, Qazilbash M, Knust K, Sahebi F, Weisdorf D, Vesole D, Stadtmauer E, Maloney D, et al. Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. British Journal of Haematology. PMID 27292583 DOI: 10.1111/Bjh.14170 |
0.398 |
|
| 2016 |
Laport GG, Wu J, Logan B, Bachanova V, Hosing C, Fenske T, Longo W, Devine SM, Nademanee A, Gersten I, Horowitz M, Lazarus HM, Riches ML. Reduced Intensity Conditioning with Fludarabine, Cyclophosphamide, and High Dose Rituxan for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase II Multicenter Trial from the Blood and Marrow Transplant Network (BMT CTN). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27118571 DOI: 10.1016/J.Bbmt.2016.04.014 |
0.513 |
|
| 2016 |
Burns LJ, Logan BR, Chitphakdithai P, Miller JP, Drexler R, Spellman S, Switzer GE, Wingard JR, Anasetti C, Confer DL. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Bone Marrow: A Prespecified Analysis from the Phase III BMT CTN Protocol 0201. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27013014 DOI: 10.1016/J.Bbmt.2016.02.018 |
0.51 |
|
| 2016 |
Sparapani RA, Logan BR, McCulloch RE, Laud PW. Nonparametric survival analysis using Bayesian Additive Regression Trees (BART). Statistics in Medicine. PMID 26854022 DOI: 10.1002/Sim.6893 |
0.372 |
|
| 2016 |
Stroncek D, Shaw BE, Logan B, Kiefer DM, Chitphakdithai P, Switzer GE, Shah NN, Miller JP, Confer DL, Pulsipher MA. Pain, Symptoms, AEs, and Recovery after Second Unrelated Donor Collection of Marrow/Peripheral Blood Stem Cells Are Similar to Those of the First Donation Blood. 128: 2177-2177. DOI: 10.1182/Blood.V128.22.2177.2177 |
0.417 |
|
| 2016 |
Shenoy S, Eapen M, Wu J(, Walters MC, Levine JE, Logan BR, Gersten ID, Kamani NR. Results of the Blood and Marrow Transplant Clinical Trials Network Study BMT CTN 0601: Scurt - a Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation (BMT) for Children with Severe Sickle Cell Disease Biology of Blood and Marrow Transplantation. 22: S104. DOI: 10.1016/J.Bbmt.2015.11.407 |
0.468 |
|
| 2016 |
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Puck J, Fleisher T, Griffith LM, Kohn DB, Pulsipher MA, Shearer W, Hanson IC, Kapoor N, O'Reilly RJ, Boyer M, Pai S, et al. Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc Biology of Blood and Marrow Transplantation. 22: S101-S102. DOI: 10.1016/J.Bbmt.2015.11.404 |
0.442 |
|
| 2016 |
Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Switzer GE, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Shaw BE, O'Donnell PV, Miller JP, et al. Pain, Donation-Related Symptoms and the Trajectory of Recovery in Children after Bone Marrow (BM) Donation Are Influenced By Age (Pre vs. Post-Puberty) and Sex: Primary Analysis of the Pediatric Toxicity Cohort of the Related Donor Safety Study (RDSafe) Biology of Blood and Marrow Transplantation. 22: S93-S94. DOI: 10.1016/J.Bbmt.2015.11.394 |
0.335 |
|
| 2016 |
Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Alousi AM, Horowitz MM, Abhyankar S, Waller EK, Mendizabal A, Wang Y, Lazaryan A, et al. Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network Biology of Blood and Marrow Transplantation. 22: S50-S52. DOI: 10.1016/J.Bbmt.2015.11.336 |
0.445 |
|
| 2016 |
Knight JM, Martens M, Syrjala KL, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim H, Wingard JR, Horowitz MM, Majhail NS, Abidi MH, Geller NL, Fei M, et al. Abstract # 1729 Psychosocial and socioeconomic status as predictors of outcomes following hematopoietic stem cell transplantation: An ancillary study from the BMT CTN 0902 randomized controlled trial (RCT) Brain Behavior and Immunity. 57. DOI: 10.1016/J.Bbi.2016.07.028 |
0.502 |
|
| 2015 |
Brazauskas R, Logan BR. Observational Studies: Matching or Regression? Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26712591 DOI: 10.1016/J.Bbmt.2015.12.005 |
0.389 |
|
| 2015 |
Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp ZM, Kasow KA, Abidi MH, Savani BN, Shah NN, ... ... Logan BR, et al. Significant improvements in the practice patterns of adult related donor care in US transplant centers. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26597080 DOI: 10.1016/J.Bbmt.2015.11.008 |
0.469 |
|
| 2015 |
Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE. EBMT transplant centers with FACT-JACIE accreditation have significantly better compliance with related donor care standards. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26597079 DOI: 10.1016/J.Bbmt.2015.11.009 |
0.424 |
|
| 2015 |
Young JH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JW, Langston AA, et al. Infections following Transplantation of Bone Marrow or Peripheral-Blood Stem Cells from Unrelated Donors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26409243 DOI: 10.1016/J.Bbmt.2015.09.013 |
0.473 |
|
| 2015 |
Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JM, Ma J, Cole SW. Low socioeconomic status, adverse gene expression profiles, and clinical outcomes in hematopoietic stem cell transplant recipients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26286914 DOI: 10.1158/1078-0432.Ccr-15-1344 |
0.407 |
|
| 2015 |
Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, et al. An Analysis of the Effect of Race, Socioeconomic Status and Center Size on Unrelated NMDP Donor Outcomes: Donor Toxicities are More Common at Low Volume Bone Marrow Collection Centers. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26116089 DOI: 10.1016/J.Bbmt.2015.06.013 |
0.415 |
|
| 2015 |
Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1479-87. PMID 25862591 DOI: 10.1016/J.Bbmt.2015.04.004 |
0.534 |
|
| 2015 |
Majhail NS, Mau LW, Chitphakdithai P, Payton T, Eckrich M, Joffe S, Lee SJ, LeMaistre CF, LeRademacher J, Loberiza F, Logan B, Parsons SK, Repaczki-Jones R, Robinett P, Rizzo JD, et al. National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1308-14. PMID 25840337 DOI: 10.1016/J.Bbmt.2015.03.020 |
0.452 |
|
| 2015 |
Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringdén OT, Pasquini MC, Schriber JR, et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. PMID 25772027 DOI: 10.1038/Leu.2015.75 |
0.474 |
|
| 2015 |
Chen YB, Lane AA, Logan BR, Zhu X, Akpek G, Aljurf MD, Artz AS, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson RF, Saber W, McCarthy PL, Pasquini MC. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1046-53. PMID 25687795 DOI: 10.1016/J.Bbmt.2015.02.005 |
0.45 |
|
| 2015 |
Logan AC, Wang Z, Alimoghaddam K, Wong RM, Lai T, Negrin RS, Grumet C, Logan BR, Zhang MJ, Spellman SR, Lee SJ, Miklos DB. ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 746-54. PMID 25572032 DOI: 10.1016/J.Bbmt.2014.12.036 |
0.522 |
|
| 2015 |
Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, et al. Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 688-95. PMID 25543094 DOI: 10.1016/J.Bbmt.2014.12.017 |
0.437 |
|
| 2015 |
Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Champlin RE. Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 364-9. PMID 25534391 DOI: 10.1200/Jco.2014.57.2446 |
0.495 |
|
| 2015 |
Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, de Lima M, Bunjes DW, Zhang MJ. Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 454-9. PMID 25460355 DOI: 10.1016/J.Bbmt.2014.11.007 |
0.486 |
|
| 2015 |
Majhail NS, Chitphakdithai P, Logan B, King R, Devine S, Rossmann SN, Hale G, Hartzman RJ, Karanes C, Laport GG, Nemecek E, Snyder EL, Switzer GE, Miller J, Navarro W, et al. Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 142-50. PMID 25445638 DOI: 10.1016/J.Bbmt.2014.10.001 |
0.515 |
|
| 2015 |
Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ, Logan B, Pasquini M, Pulsipher M, Stadtmauer E, Wingard JR, et al. Blood and marrow transplant clinical trials network state of the Science Symposium 2014. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 202-24. PMID 25445636 DOI: 10.1016/J.Bbmt.2014.10.003 |
0.436 |
|
| 2015 |
Hong S, Le-Rademacher J, Artz A, McCarthy PL, Logan BR, Pasquini MC. Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders. Bone Marrow Transplantation. 50: 367-74. PMID 25437248 DOI: 10.1038/Bmt.2014.269 |
0.486 |
|
| 2015 |
Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, et al. Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 165-71. PMID 25316111 DOI: 10.1016/J.Bbmt.2014.10.007 |
0.44 |
|
| 2015 |
Barker JN, Fei M, Karanes C, Horwitz M, Devine S, Kindwall-Keller TL, Holter J, Adams A, Logan B, Navarro WH, Riches M. Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia. British Journal of Haematology. 168: 405-12. PMID 25272241 DOI: 10.1111/Bjh.13136 |
0.499 |
|
| 2015 |
Eapen M, Logan BR, Appelbaum FR, Antin JH, Anasetti C, Couriel DR, Chen J, Maziarz RT, McCarthy PL, Nakamura R, Ratanatharathorn V, Vij R, Champlin RE. Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 55-9. PMID 25255165 DOI: 10.1016/J.Bbmt.2014.09.006 |
0.526 |
|
| 2015 |
Logan BR, Mo S. Group sequential tests for long-term survival comparisons. Lifetime Data Analysis. 21: 218-40. PMID 25053470 DOI: 10.1007/S10985-014-9298-4 |
0.39 |
|
| 2015 |
Scott BL, Pasquini MC, Logan B, Wu J, Devine S, Porter DL, Maziarz RT, Warlick E, Fernandez HF, Alyea EP, Hamadani M, Bashey A, Giralt SA, Leifer E, Geller N, et al. Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901 Blood. 126: LBA-8-LBA-8. DOI: 10.1182/Blood.V126.23.Lba-8.Lba-8 |
0.47 |
|
| 2015 |
Shenoy S, Eapen M, Wu J, Walters MC, Levine JE, Logan B, Gersten ID, Kamani NR. A Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation for Children with Severe Sickle Cell Disease (SCURT): Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0601) Study Blood. 126: 619-619. DOI: 10.1182/Blood.V126.23.619.619 |
0.509 |
|
| 2015 |
Lee SJ, Logan B, Westervelt P, Cutler CS, Woolfrey AE, Khan S, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer DL, Horowitz MM, Anasetti C. 5 Year Results of BMT CTN 0201: Unrelated Donor Bone Marrow Is Associated with Better Psychological Well-Being and Less Burdensome Chronic Gvhd Symptoms Than Peripheral Blood Blood. 126: 270-270. DOI: 10.1182/Blood.V126.23.270.270 |
0.486 |
|
| 2015 |
Atallah E, Horowitz MM, Logan B, Chen M, Boo MJ, Cutler CS, Deeg J, Gajewski JL, Confer DL, Farnia S, Greenberg P, Warlick E, Weisdorf D, Rizzo JD. Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age Blood. 126: 193-193. DOI: 10.1182/Blood.V126.23.193.193 |
0.456 |
|
| 2015 |
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck J, Parikh S, O'Reilly RJ, Pai S, Hanson IC, Martinez C, Pulsipher MA, Kapoor N, Goldman F, Kletzel M, et al. Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901 Biology of Blood and Marrow Transplantation. 21: S289-S291. DOI: 10.1016/J.Bbmt.2014.11.459 |
0.436 |
|
| 2015 |
Knight J, Cole S, Logan BR, Wang T, Rizzo JD. Clinical Outcomes Among Unrelated Donor Transplant Recipients for Acute Myelogenous Leukemia As a Function of Socioeconomic Status and Related Transcriptome Differences Biology of Blood and Marrow Transplantation. 21: S76-S77. DOI: 10.1016/J.Bbmt.2014.11.086 |
0.471 |
|
| 2015 |
Young JH, Logan BR, Wu J(, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Anasetti C. More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors Biology of Blood and Marrow Transplantation. 21: S49-S50. DOI: 10.1016/J.Bbmt.2014.11.044 |
0.441 |
|
| 2015 |
Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Switzer GE, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, King RJ, et al. Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe) Biology of Blood and Marrow Transplantation. 21: S41-S42. DOI: 10.1016/J.Bbmt.2014.11.034 |
0.368 |
|
| 2015 |
Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Stroncek DF, Williams EP, O'Donnell PV, Majhail NS, Confer DL, Shaw BE. The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers Biology of Blood and Marrow Transplantation. 21: S40-S41. DOI: 10.1016/J.Bbmt.2014.11.033 |
0.391 |
|
| 2014 |
Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ, Levine JE, MacMillan ML, Martin PJ, Mendizabal AM, Nakamura R, et al. Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. Blood. 124: 3221-7; quiz 3335. PMID 25170121 DOI: 10.1182/Blood-2014-06-577023 |
0.438 |
|
| 2014 |
Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, Sullivan KE, Small TN, Burroughs L, Skoda-Smith S, Haight AE, et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. The New England Journal of Medicine. 371: 434-46. PMID 25075835 DOI: 10.1056/Nejmoa1401177 |
0.452 |
|
| 2014 |
Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu JW, Waller EK, Grupp S, McCarthy P, Wu J, Hu ZH, et al. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. Blood. 124: 1372-7. PMID 24982504 DOI: 10.1182/Blood-2014-04-567164 |
0.474 |
|
| 2014 |
Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, et al. Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2365-72. PMID 24982459 DOI: 10.1200/Jco.2013.54.4577 |
0.511 |
|
| 2014 |
Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS. Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1566-72. PMID 24972249 DOI: 10.1016/J.Bbmt.2014.06.010 |
0.493 |
|
| 2014 |
Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, et al. Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1530-6. PMID 24910380 DOI: 10.1016/J.Bbmt.2014.05.027 |
0.375 |
|
| 2014 |
Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer EA, Vesole DH, Logan B, Weisdorf D, Qazilbash M, Popplewell LL, McClune B, Bensinger W, Riches M, et al. Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1183-9. PMID 24769014 DOI: 10.1016/J.Bbmt.2014.04.014 |
0.503 |
|
| 2014 |
Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 123: 3664-71. PMID 24744269 DOI: 10.1182/Blood-2014-01-552984 |
0.502 |
|
| 2014 |
Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation. Blood. 123: 3655-63. PMID 24735965 DOI: 10.1182/Blood-2013-12-542464 |
0.411 |
|
| 2014 |
Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho VT, Soiffer RJ, Carter SL, Wu J, Wingard JR, Difronzo NL, Ferrara JL, Giralt S, Madtes DK, Drexler R, White ES, et al. Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 858-64. PMID 24607553 DOI: 10.1016/J.Bbmt.2014.02.026 |
0.451 |
|
| 2014 |
Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, Griffith LM, Kohn DB, O'Reilly RJ, Fleisher TA, Pai SY, Martinez CA, Buckley RH, Cowan MJ. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. The Journal of Allergy and Clinical Immunology. 133: 1092-8. PMID 24290292 DOI: 10.1016/J.Jaci.2013.09.044 |
0.392 |
|
| 2014 |
Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Pai SY, Ballard B, Bauer SC, Bleesing JJ, Boyle M, Brower A, Buckley RH, van der Burg M, Burroughs LM, Candotti F, ... ... Logan BR, et al. Primary Immune Deficiency Treatment Consortium (PIDTC) report. The Journal of Allergy and Clinical Immunology. 133: 335-47. PMID 24139498 DOI: 10.1016/J.Jaci.2013.07.052 |
0.372 |
|
| 2014 |
Laport GG, Wu J, Logan BR, Bachanova V, Hosing CM, Fenske TS, Longo WL, Devine SM, Nademanee AP, Gersten I, Horowitz MM, Lazarus HM, Riches ML. Reduced Intensity Conditioning (RIC) with Rituximab Yields Excellent Outcomes after Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Relapsed Follicuar Lymphoma (FL): A Phase II Multicenter Trial from the Blood and Marrow Transplant Network (BMT CTN 0701) Blood. 124: 682-682. DOI: 10.1182/Blood.V124.21.682.682 |
0.495 |
|
| 2014 |
Artz AS, Logan BR, Zhu X, Akpek G, Martino R, Gupta V, Lazarus HM, Litzow MR, Loren AW, Majhail NS, Maziarz RT, McCarthy PL, Popat UR, Saber W, Spellman SR, et al. Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT) Blood. 124: 422-422. DOI: 10.1182/Blood.V124.21.422.422 |
0.443 |
|
| 2014 |
Wood WA, Le-Rademacher J, Fei M, Logan BR, Syrjala KL, Majhail NS, Wingard JR, Abidi MH, Geller NL, Wu J, Rizzo JD, Faber EA, Jim H, Jacobsen P, Horowitz MM, et al. Patient-Reported Quality of Life Is an Independent Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation: A Secondary Analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902 Blood. 124: 206-206. DOI: 10.1182/Blood.V124.21.206.206 |
0.487 |
|
| 2014 |
Chen Y, Lane AA, Logan BR, Maziarz RT, Zhu X, Akpek G, Lazarus HM, Bredeson CN, Olsson R, Saber W, Hale GA, Smith FO, Aljurf MD, Artz AS, Ho VT, et al. Incidence and Risk Factors for the Development of Idiopathic Pneumonitis Syndrome (IPS) after Autologous Hematopoietic Cell Transplantation (AutoHCT) for Patients with Lymphoma Biology of Blood and Marrow Transplantation. 20: S106. DOI: 10.1016/J.Bbmt.2013.12.148 |
0.415 |
|
| 2014 |
Pulsipher MA, Chitphakdithai P, Logan BR, Switzer GE, Tomblyn MR, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Hays A, Kobusingye H, Miller JP, Drexler RJ, King R, Horowitz MM, et al. Related PBSC Donors Age >60 Have High Rates of Baseline and Donation-Related Pain and Slow Recovery: First Report from the Related Donor Safety Study (RDSafe) Biology of Blood and Marrow Transplantation. 20: S41-S42. DOI: 10.1016/J.Bbmt.2013.12.034 |
0.334 |
|
| 2014 |
Pai S, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich A, Jyonouchi S, Small T, Burroughs L, Haight AE, Pulsipher MA, Chan KW, et al. Retrospective Study of 240 Patients with Severe Combined Immunodeficiency Transplanted from 2000-2009: A Report from the Primary Immune Deficiency Treatment Consortium of North America Biology of Blood and Marrow Transplantation. 20: S24-S25. DOI: 10.1016/J.Bbmt.2013.12.007 |
0.424 |
|
| 2013 |
Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Shearer WT, O'Reilly RJ, Fleisher TA, Pai SY, Hanson IC, Pulsipher MA, Fuleihan R, Filipovich A, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. Journal of Clinical Immunology. 33: 1156-64. PMID 23818196 DOI: 10.1007/S10875-013-9917-Y |
0.433 |
|
| 2013 |
Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, et al. Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1102-8. PMID 23632091 DOI: 10.1016/J.Bbmt.2013.04.022 |
0.536 |
|
| 2013 |
Anasetti C, Logan BR, Confer DL. Peripheral-blood versus bone marrow stem cells. The New England Journal of Medicine. 368: 288. PMID 23323911 DOI: 10.1056/Nejmc1214025 |
0.319 |
|
| 2013 |
Bolaños-Meade J, Wu J, Logan BR, Levine JE, Ho VT, Alousi AM, Weisdorf DJ, Luznik L. Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 481-5. PMID 23247045 DOI: 10.1016/J.Bbmt.2012.12.003 |
0.457 |
|
| 2013 |
Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, et al. Effects of spleen status on early outcomes after hematopoietic cell transplantation. Bone Marrow Transplantation. 48: 825-31. PMID 23222382 DOI: 10.1038/Bmt.2012.249 |
0.473 |
|
| 2013 |
Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, et al. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood. 121: 197-206. PMID 23109243 DOI: 10.1182/Blood-2012-03-417667 |
0.453 |
|
| 2013 |
Logan BR. Review of multistate models in hematopoietic cell transplantation studies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: S84-7. PMID 23084957 DOI: 10.1016/J.Bbmt.2012.10.016 |
0.416 |
|
| 2013 |
Logan BR, Zhang MJ. The use of group sequential designs with common competing risks tests. Statistics in Medicine. 32: 899-913. PMID 22945865 DOI: 10.1002/Sim.5597 |
0.378 |
|
| 2013 |
Lee SJ, Le Rademacher J, Jim H, Syrjala KL, Wingard JR, Logan BR, Wu J, Majhail NS, Wood WA, Rizzo JD, Geller NL, Kitko CL, Faber EA, Abidi MH, Slater SE, et al. Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902 Blood. 122: 699-699. DOI: 10.1182/Blood.V122.21.699.699 |
0.397 |
|
| 2013 |
Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Weisdorf DJ, Champlin RE. Transplantation Of Peripheral Blood Progenitor Cells (PBPC) As Compared To Bone Marrow (BM) From Unrelated Related Donors For Hematologic Cancers Using Fludarabine-Alkylating Agent Based Reduced Intensity Conditioning Regimens Blood. 122: 550-550. DOI: 10.1182/Blood.V122.21.550.550 |
0.502 |
|
| 2013 |
Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio M, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W. Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research Blood. 122: 548-548. DOI: 10.1182/Blood.V122.21.548.548 |
0.415 |
|
| 2013 |
Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Shaw BE, Goldstein SC, O’Donnell PV, Confer DL. Influence Of Race and Ethnicity On The Collection Of G-CSF Mobilized Peripheral Blood Stem Cells From Unrelated Donors, a Center For International Blood and Marrow Transplant Research Analysis Blood. 122: 3273-3273. DOI: 10.1182/Blood.V122.21.3273.3273 |
0.417 |
|
| 2013 |
Bejanyan N, Weisdorf DJ, Wang H, Logan BR, Devine SM, de Lima M, Bunjes DW, Zhang M. Survival Of AML Patients Relapsing After Allogeneic Stem Cell Transplantation: A Center For International Blood and Marrow Transplant Research Study Blood. 122: 2072-2072. DOI: 10.1182/Blood.V122.21.2072.2072 |
0.478 |
|
| 2013 |
Majhail NS, Payton T, Mau L, Le Rademacher J, Chitphakdithai P, Eckrich M, Joffe S, Lee SJ, LeMaistre CF, Loberiza FR, Logan BR, Murphy EA, Parsons SK, Repaczki-Jones R, Rizzo JD, et al. Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR) Blood. 122: 1687-1687. DOI: 10.1182/Blood.V122.21.1687.1687 |
0.488 |
|
| 2013 |
Yanik G, Ho VT, Horowitz M, Weisdorf DJ, Logan BR, Wu J, Soiffer RJ, Wingard JR, Levine JE, Ferrara JL, Giralt SA, White E, Carter SL, DiFronzo N, Cooke KR. Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (ETANERCEPT) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study Biology of Blood and Marrow Transplantation. 19: S169. DOI: 10.1016/J.Bbmt.2012.11.141 |
0.46 |
|
| 2013 |
Becker PS, Alsina M, Zhong X, Hari PN, Rowley S, Stadtmauer EA, Vesole D, Logan BR, Weisdorf DJ, Qazilbash M, Popplewell L, Navarro WH, Tomblyn M, Giralt SA, Pasquini MC. Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM) Biology of Blood and Marrow Transplantation. 19: S154. DOI: 10.1016/J.Bbmt.2012.11.111 |
0.452 |
|
| 2013 |
Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Hexner EO, Horowitz MM, Levine JE, MacMillan ML, Martin PJ, Nakamura R, Pasquini MC, Weisdorf DJ, Westervelt P, et al. A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802 Biology of Blood and Marrow Transplantation. 19: S137. DOI: 10.1016/J.Bbmt.2012.11.076 |
0.428 |
|
| 2012 |
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. The New England Journal of Medicine. 367: 1487-96. PMID 23075175 DOI: 10.1056/Nejmoa1203517 |
0.497 |
|
| 2012 |
Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood. 120: 259-65. PMID 22596257 DOI: 10.1182/Blood-2012-03-379032 |
0.505 |
|
| 2012 |
Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL. Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1204-10. PMID 22406037 DOI: 10.1016/J.Bbmt.2012.01.007 |
0.528 |
|
| 2012 |
Levine JE, Logan BR, Wu J, Alousi AM, Bolaños-Meade J, Ferrara JL, Ho VT, Weisdorf DJ, Paczesny S. Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. Blood. 119: 3854-60. PMID 22383800 DOI: 10.1182/Blood-2012-01-403063 |
0.467 |
|
| 2012 |
Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, et al. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1265-72. PMID 22343376 DOI: 10.1016/J.Bbmt.2012.01.019 |
0.543 |
|
| 2012 |
Pasquini MC, Logan BR, Ho VT, McCarthy PL, Cooke KR, Rizzo JD, Zhu X, Sorror ML. Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI Blood. 120: 814-814. DOI: 10.1182/Blood.V120.21.814.814 |
0.459 |
|
| 2012 |
Cutler C, Logan BR, Nakamura R, Johnston L, Choi SW, Porter DL, Hogan WJ, Pasquini MC, MacMillan ML, Wingard JR, Waller EK, Grupp SA, McCarthy PL, Wu J, Hu Z, et al. Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402 Blood. 120: 739-739. DOI: 10.1182/Blood.V120.21.739.739 |
0.498 |
|
| 2012 |
Thakar MS, Logan BR, Pasquini MC, McCarthy PL, Ho VT, Cooke KR, Zhu X, Rizzo JD, Sorror ML. The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases Blood. 120: 737-737. DOI: 10.1182/Blood.V120.21.737.737 |
0.412 |
|
| 2012 |
Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Storer B, Pasquini MC. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study Blood. 120: 733-733. DOI: 10.1182/Blood.V120.21.733.733 |
0.434 |
|
| 2012 |
Kamani N, Walters M, Carter S, Brochstein J, Eapen M, Levine J, Logan B, Panepinto J, Parikh S, Pulsipher M, Schultz K, Shenoy S. Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of a Phase II Study from the Blood and Marrow Transplant Clinical Trials Network Biology of Blood and Marrow Transplantation. 18: S326. DOI: 10.1016/J.Bbmt.2011.12.318 |
0.468 |
|
| 2011 |
Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E, Antin JH, Comenzo R, Goodman S, Hari P, Laport G, Qazilbash MH, Rowley S, Sahebi F, Somlo G, et al. Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. The Lancet. Oncology. 12: 1195-203. PMID 21962393 DOI: 10.1016/S1470-2045(11)70243-1 |
0.51 |
|
| 2011 |
Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, et al. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 805-13. PMID 21220593 DOI: 10.1200/Jco.2010.32.5001 |
0.492 |
|
| 2011 |
Sabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li CK, Irfan SM, Bredeson CN, Cowan MJ, Gale RP, Hale GA, Horan J, Hongeng S, Eapen M, Walters MC. HLA-matched sibling bone marrow transplantation for β-thalassemia major. Blood. 117: 1745-50. PMID 21119108 DOI: 10.1182/Blood-2010-09-306829 |
0.482 |
|
| 2011 |
Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC. Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 737-44. PMID 20817111 DOI: 10.1016/J.Bbmt.2010.08.019 |
0.442 |
|
| 2011 |
Hari P, Pasquini MC, Logan BR, Stadtmauer EA, Krishnan A, Howard A, Alvi S, Harding S, Carter SL, Rajkumar V, Alyea EP, Qazilbash M, Laport GG, Maloney DG, Giralt S, et al. Immunoglobulin Free Light Chain (FLC) and Heavy Chain/Light Chain (HLC) Assays – Comparison with Electrophoretic Responses in Multiple Myeloma (MM) Blood. 118: 2877-2877. DOI: 10.1182/Blood.V118.21.2877.2877 |
0.374 |
|
| 2011 |
Waller EK, Harris WA, Devine S, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Gurgol C, Logan BR, Confer DL, et al. Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201 Blood. 118: 1004-1004. DOI: 10.1182/Blood.V118.21.1004.1004 |
0.528 |
|
| 2011 |
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Johnston L, Maziarz RT, Pulsipher M, Anderlini P, Bensinger WI, et al. Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial Blood. 118: 1-1. DOI: 10.1182/Blood.V118.21.1.1 |
0.55 |
|
| 2010 |
Levine JE, Logan B, Wu J, Alousi AM, Ho V, Bolaños-Meade J, Weisdorf D. Graft-versus-host disease treatment: predictors of survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 1693-9. PMID 20541024 DOI: 10.1016/J.Bbmt.2010.05.019 |
0.44 |
|
| 2010 |
Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, et al. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 116: 1839-48. PMID 20538804 DOI: 10.1182/Blood-2010-04-278317 |
0.473 |
|
| 2010 |
Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, et al. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 1442-50. PMID 20412867 DOI: 10.1016/J.Bbmt.2010.04.009 |
0.446 |
|
| 2010 |
Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, et al. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 1099-106. PMID 20172038 DOI: 10.1016/J.Bbmt.2010.02.013 |
0.519 |
|
| 2010 |
Jacobson PA, Huang J, Wu J, Kim M, Logan B, Alousi A, Grimley M, Bolaños-Meade J, Ho V, Levine JE, Weisdorf D. Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 421-9. PMID 19925875 DOI: 10.1016/J.Bbmt.2009.11.010 |
0.424 |
|
| 2010 |
Akpek G, Pasquini MC, Agovi M, Logan B, Cooke KR, Maziarz RT, Gupta V, Lazarus HM, Hale GA, Marks DI, Maharaj D, Popat U, Carabasi M, Bornhaeuser M, Bolwell BJ, et al. Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT). Blood. 116: 3486-3486. DOI: 10.1182/Blood.V116.21.3486.3486 |
0.477 |
|
| 2010 |
Pulsipher MA, Chitphakdithai P, Logan BR, Goldstein SC, Levine JE, Lankiewicz M, Stroncek D, Confer DL. Peripheral Blood Stem Cell (PBSC) Donors Experience Higher Levels of Pain and Toxicities Early On, While Bone Marrow (BM) Donors Experience Slower Recovery and More Late Pain: A Prospective Study of the National Marrow Donor Program (NMDP). Blood. 116: 1107-1107. DOI: 10.1182/Blood.V116.21.1107.1107 |
0.455 |
|
| 2010 |
Jacobson P, Juang J, Wu J, Kim M, Logan B, Alousi A, Grimley M, Bolaños-Meade J, Ho V, Levine J, Weisdorf D. Mycophenolate Pharmacokinetics And Association With Response To Acute Graft vs Host Disease (GVHD) Treatment Biology of Blood and Marrow Transplantation. 16: S299-S300. DOI: 10.1016/J.Bbmt.2009.12.430 |
0.364 |
|
| 2010 |
Thiel E, Zhang M, Davies S, Kurtzberg J, Logan B, Ayas M, MacMillian M, Tiedemann K, Eapen M. Comparable Long-Term Leukemia-Free Survival After Matched Sibling And Unrelated Donor Transplantation For Children With Acute Lymphoblastic Leukemia In Second Complete Remission Biology of Blood and Marrow Transplantation. 16: S267. DOI: 10.1016/J.Bbmt.2009.12.338 |
0.441 |
|
| 2009 |
Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, Burns LJ, Gupta V, Ho V, McCarthy PL, Ringdén O, Schouten HC, Seftel M, Rizzo JD. The effect of smoking on allogeneic transplant outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 1277-87. PMID 19747636 DOI: 10.1016/J.Bbmt.2009.06.005 |
0.428 |
|
| 2009 |
Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL. Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood. 114: 2606-16. PMID 19608747 DOI: 10.1182/Blood-2009-03-208355 |
0.512 |
|
| 2009 |
Alousi AM, Weisdorf DJ, Logan BR, Bolaños-Meade J, Carter S, Difronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood. 114: 511-7. PMID 19443659 DOI: 10.1182/Blood-2009-03-212290 |
0.511 |
|
| 2009 |
van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R, Nelson G, Fay JW, Champlin RE, Lazarus HM, Vose JM, Hari PN. Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 554-63. PMID 19361747 DOI: 10.1016/J.Bbmt.2009.01.012 |
0.529 |
|
| 2009 |
Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, et al. Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation. British Journal of Haematology. 145: 816-24. PMID 19344418 DOI: 10.1111/J.1365-2141.2009.07674.X |
0.505 |
|
| 2009 |
Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 113: 3604-11. PMID 19190248 DOI: 10.1182/Blood-2008-08-175323 |
0.471 |
|
| 2009 |
Gale RP, Eapen M, Logan B, Zhang M-, Lazarus HM. Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants Bone Marrow Transplantation. 43: 435-446. PMID 19182830 DOI: 10.1038/Bmt.2008.447 |
0.406 |
|
| 2009 |
Tunes da Silva G, Logan BR, Klein JP. Methods for equivalence and noninferiority testing. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 120-7. PMID 19147090 DOI: 10.1016/J.Bbmt.2008.10.004 |
0.373 |
|
| 2009 |
Devetten MP, Hari PN, Carreras J, Logan BR, van Besien K, Bredeson CN, Freytes CO, Gale RP, Gibson J, Giralt SA, Goldstein SC, Gupta V, Marks DI, Maziarz RT, Vose JM, et al. Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 109-17. PMID 19135949 DOI: 10.1016/J.Bbmt.2008.11.011 |
0.555 |
|
| 2009 |
Barker CC, Agovi MA, Logan B, Gupta V, Lazarus HM, Ballen KK, Hale GA, Frangoul H, Rizzo JD, Pasquini MC. Obesity Adversely Affects Survival of Pediatric Patients with Severe Aplastic Anemia After Hematopoietic Cell Transplantation. Blood. 114: 652-652. DOI: 10.1182/Blood.V114.22.652.652 |
0.456 |
|
| 2009 |
Horan J, Logan BR, Agovi M, Lazarus HM, Bacigalupo A, Ballen K, Martino R, Juckett MB, Khoury HJ, Bredeson C, Gupta V, Smith FO, Hale G, Carabasi M, McCarthy PL, et al. Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?. Blood. 114: 649-649. DOI: 10.1182/Blood.V114.22.649.649 |
0.528 |
|
| 2009 |
Gupta V, Tallman MS, He W, Logan B, DiPersio JF, Bunjes DW, Weisdorf DJ. Comparable Disease-Free and Overall Survival After “Well-Matched” Unrelated Donor and Matched Sibling Donor Transplantation in Acute Myeloid Leukemia with Adverse Risk Karyotype in First Complete Remission: A Report From the Acute Leukemia Working Committee of the Centre for International Blood and Marrow Transplant Research. Blood. 114: 526-526. DOI: 10.1182/Blood.V114.22.526.526 |
0.515 |
|
| 2009 |
Sabloff M, Chandy M, Wang Z, Logan B, Li C, Irfan SM, Eapen M, Walters MC. Bone Marrow Transplantation From HLA-Identical Sibling for Thalassemia. Blood. 114: 3361-3361. DOI: 10.1182/Blood.V114.22.3361.3361 |
0.514 |
|
| 2009 |
Gale RP, Eapen M, Logan B, Zhang M, Lazarus HM. Erratum: Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? Bone Marrow Transplantation. 43: 743-743. DOI: 10.1038/Bmt.2009.72 |
0.395 |
|
| 2008 |
Logan B, Leifer E, Bredeson C, Horowitz M, Ewell M, Carter S, Geller N. Use of biological assignment in hematopoietic stem cell transplantation clinical trials. Clinical Trials (London, England). 5: 607-16. PMID 19029209 DOI: 10.1177/1740774508098326 |
0.473 |
|
| 2008 |
Logan BR, Tamhane AC. Superiority inferences on individual endpoints following noninferiority testing in clinical trials. Biometrical Journal. Biometrische Zeitschrift. 50: 693-703. PMID 18932132 DOI: 10.1002/Bimj.200710447 |
0.58 |
|
| 2008 |
Logan BR, Nelson GO, Klein JP. Analyzing center specific outcomes in hematopoietic cell transplantation. Lifetime Data Analysis. 14: 389-404. PMID 18836830 DOI: 10.1007/S10985-008-9100-6 |
0.487 |
|
| 2008 |
Liu L, Logan B, Klein JP. Inference for current leukemia free survival. Lifetime Data Analysis. 14: 432-46. PMID 18663574 DOI: 10.1007/S10985-008-9093-1 |
0.49 |
|
| 2008 |
Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM. Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 28: 243-53. PMID 18349441 DOI: 10.1177/0272989X07308750 |
0.402 |
|
| 2008 |
Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 316-22. PMID 18275898 DOI: 10.1016/J.Bbmt.2007.12.493 |
0.468 |
|
| 2008 |
Logan BR, Klein JP, Zhang MJ. Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. Biometrics. 64: 733-40. PMID 18190619 DOI: 10.1111/J.1541-0420.2007.00975.X |
0.419 |
|
| 2008 |
Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1-6. PMID 18158954 DOI: 10.1016/J.Bbmt.2007.11.003 |
0.433 |
|
| 2008 |
Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, et al. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. Bone Marrow Transplantation. 41: 635-42. PMID 18084335 DOI: 10.1038/Sj.Bmt.1705952 |
0.505 |
|
| 2008 |
Alousi A, Weisdorf DJ, Logan BR, Bolanos-Meade J, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE. BMT CTN 0302: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox, and Pentostatin in Combination with Corticosteroids in 180 Patients (pts) with Newly Diagnosed Acute Graft Vs. Host Disease (aGVHD) Blood. 112: 55-55. DOI: 10.1182/Blood.V112.11.55.55 |
0.366 |
|
| 2008 |
Navarro WH, Agovi M, Logan B, Bacigalupo A, Ballen KK, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Juckett M, Lazarus HM, Litzow MR, Liesveld J, Moreb J, Marks D, et al. Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults Blood. 112: 51-51. DOI: 10.1182/Blood.V112.11.51.51 |
0.457 |
|
| 2008 |
Pulsipher M, Chitphakdithai P, Logan B, Leitman S, Anderlini P, Klein J, Horowitz M, Miller J, King R, Confer D. 40: Outcomes of a Prospective Trial of NMDP-Facilitated Unrelated Donor (UD) PBSC Hematopoietic Cell Transplantation (HCT) for Leukemia and Myelodysplasia: Comparable Survival Regardless of Regimen Intensity and Improved Survival with Higher Cell Doses Biology of Blood and Marrow Transplantation. 14: 17. DOI: 10.1016/J.Bbmt.2007.12.048 |
0.494 |
|
| 2007 |
Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1461-8. PMID 18022576 DOI: 10.1016/J.Bbmt.2007.08.006 |
0.543 |
|
| 2007 |
Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 844-52. PMID 17580263 DOI: 10.1016/J.Bbmt.2007.03.011 |
0.542 |
|
| 2007 |
Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD. Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 778-89. PMID 17580256 DOI: 10.1016/J.Bbmt.2007.02.013 |
0.522 |
|
| 2007 |
Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, Pérez WS, Rowe JM, Wetzler M, Weisdorf DJ. Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood. 110: 409-17. PMID 17374741 DOI: 10.1182/Blood-2006-10-043299 |
0.46 |
|
| 2007 |
Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Statistics in Medicine. 26: 4505-19. PMID 17348080 DOI: 10.1002/Sim.2864 |
0.383 |
|
| 2007 |
Gorski J, Chen X, Gendelman M, Yassai M, Krueger A, Tivol E, Logan B, Komorowski R, Vodanovic-Jankovic S, Drobyski WR. Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment. Blood. 109: 5502-10. PMID 17347406 DOI: 10.1182/Blood-2006-12-061713 |
0.333 |
|
| 2007 |
Howard A, Williams E, Logan B, Coleman L, Ng J, Maiers M, Setterholm M. 114-P: Comparison of patient-directed requests between two donor cohorts differing only in the presence of HLA-C typing Human Immunology. 68: S72. DOI: 10.1016/J.Humimm.2007.08.137 |
0.352 |
|
| 2006 |
Logan BR, Zhang MJ, Klein JP. Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 107-12. PMID 16399594 DOI: 10.1016/J.Bbmt.2005.09.005 |
0.412 |
|
| 2006 |
Devetten MP, Hari P, Carerras J, Logan BR, van Besien K, Vose JM, Lazarus HM, Anderlini P. Unrelated Donor Nonmyeloablative/Reduced Intensity (NST/RIC) Hematopoietic Stem Cell Transplantation (HCT) for Patients with Relapsed and Refractory Hodgkin’s Lymphoma (HL). Blood. 108: 601-601. DOI: 10.1182/Blood.V108.11.601.601 |
0.485 |
|
| 2006 |
Rodriguez MFN, Senegaglia AC, Rebelatto CK, Pilonetto DV, Fadel S, Malvezzi M, Logan BR, Ascenço H, Takahashi L, Pasquini R, Pereira NF. CFU-GM Assay Can Be Predictive of Umbilical Cord Blood Engraftment. Blood. 108: 5212-5212. DOI: 10.1182/Blood.V108.11.5212.5212 |
0.403 |
|
| 2006 |
Pulsipher M, Chitphakdithai P, Klein J, Kurian S, Leitman S, Anderlini P, Logan B, Horowitz MM, Confer DL. Volunteer Unrelated Donor PBSC Collection Efficacy and Recipient Outcomes: Results of a Prospective National Marrow Donor Program (NMDP) Trial, 1999–2003. Blood. 108: 169-169. DOI: 10.1182/Blood.V108.11.169.169 |
0.472 |
|
| 2005 |
Logan BR, Wang H, Zhang MJ. Pairwise multiple comparison adjustment in survival analysis. Statistics in Medicine. 24: 2509-23. PMID 15977296 DOI: 10.1002/Sim.2125 |
0.404 |
|
| 2005 |
Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, Cutler C, Ho VT, Richardson PG, Schlossman RL, Fisher DC, Logan B, Soiffer RJ. Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplantation. 35: 77-83. PMID 15502851 DOI: 10.1038/Sj.Bmt.1704709 |
0.461 |
|
| 2005 |
Gendelman M, Halligan N, Komorowski R, Logan B, Murphy WJ, Blazar BR, Pritchard KA, Drobyski WR. Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration. Blood. 105: 428-31. PMID 15331451 DOI: 10.1182/Blood-2004-01-0371 |
0.387 |
|
| 2005 |
Eapen M, Haagenson M, Logan B, Confer D, Horowitz M, Wagner J, Weisdorf D, Anasetti C. Use of Peripheral Blood Grafts Is Associated with Increased Acute and Chronic Graft-Versus-Host Disease without Improved Survival after Unrelated Donor Transplantation. Blood. 106: 443-443. DOI: 10.1182/Blood.V106.11.443.443 |
0.543 |
|
| 2005 |
Pulsipher M, Kurian S, Leitman SF, Anderlini P, Haagenson M, Logan B, Horowitz MM, Confer DL. Unrelated-Donor PBSC Collection Facilitated by the NMPD, 1999–2005: Efficacy and Toxicities, Serious Unexpected Events, and Outcomes of Standard vs. Large Volume Collections. Blood. 106: 1965-1965. DOI: 10.1182/Blood.V106.11.1965.1965 |
0.379 |
|
| 2005 |
Pasquini MC, Logan BR, Verter F, Horowitz MM, Nietfeld JJ. The Likelihood of Hematopoietic Stem Cell Transplantation (HCT) in the United States: Implications for Umbilical Cord Blood Storage. Blood. 106: 1330-1330. DOI: 10.1182/Blood.V106.11.1330.1330 |
0.428 |
|
| 2004 |
Tamhane AC, Logan BR. Finding the maximum safe dose level for heteroscedastic data. Journal of Biopharmaceutical Statistics. 14: 843-56. PMID 15587967 DOI: 10.1081/Bip-200035413 |
0.574 |
|
| 2004 |
Hari P, Logan B, Drobyski WR. Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity? Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 10: 743-7. PMID 15505605 DOI: 10.1016/J.Bbmt.2004.07.006 |
0.468 |
|
| 2004 |
Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 172: 3328-36. PMID 14978141 DOI: 10.4049/Jimmunol.172.5.3328 |
0.363 |
|
| 2004 |
Hurley CK, Baxter Lowe LA, Logan B, Karanes C, Anasetti C, Weisdorf D, Confer DL. National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 9: 610-5. PMID 14569557 DOI: 10.1016/J.Bbmt.2003.08.009 |
0.45 |
|
| 2004 |
Loberiza FR, Zhang M, Rizzo JD, Lee SJ, Klein JP, Logan BR, Eapen M, Serna DS, Lemaistre CF, Horowitz MM. Patient and transplant center factors associated with 100D mortality after receiving allogeneic hematopoietic stem cell transplantation (HSCT) Journal of Clinical Oncology. 22: 6026-6026. DOI: 10.1200/Jco.2004.22.90140.6026 |
0.447 |
|
| 2004 |
Wall D, Wagner J, Laughlin M, Ballen K, Staba S, Chan KW, McGaha O, Logan B, Klein J, Arora M. Higher Cell Dose and CD34+ Content Improves Engraftment Following Unrelated Donor Cord Blood Transplantation (CBT): A Report of the National Marrow Donor Program (NMDP) Cord Blood (CB) Experience. Blood. 104: 975-975. DOI: 10.1182/Blood.V104.11.975.975 |
0.475 |
|
| 2004 |
Tallman M, Dewald G, Lazarus H, Gandham S, Nelson G, Logan B, Rowe J, Litzow M, Keating A, Mehta J, Wetzler M, Warren T, Weisdorf D. Impact of Cytogenetics on Outcome of Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Adults with AML. Blood. 104: 830-830. DOI: 10.1182/Blood.V104.11.830.830 |
0.314 |
|
| 2004 |
Giralt S, Logan B, Zhang M, McGaha O, Ballen K, Emmanouilides C, Nath R, Parker PM, Porter D, Sandmaier B, Waller E, Barker J, Pavletic S, Weisdorf D. Non-Ablative or Reduced Intensity Conditioning Regimens with Volunteer Unrelated Donor Progenitor Cell Transplantation. Blood. 104: 2751-2751. DOI: 10.1182/Blood.V104.11.2751.2751 |
0.541 |
|
| 2004 |
Tamhane AC, Logan BR. A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials Biometrika. 91: 715-727. DOI: 10.1093/Biomet/91.3.715 |
0.589 |
|
| 2002 |
Chang CC, Lorek J, Sabath DE, Li Y, Chitambar CR, Logan B, Kampalath B, Cleveland RP. Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. Blood. 100: 4671-5. PMID 12393648 DOI: 10.1182/Blood-2002-01-0104 |
0.34 |
|
| 2002 |
Tamhane AC, Logan BR. Accurate critical constants for the one-sided approximate likelihood ratio test of a normal mean vector when the covariance matrix is estimated. Biometrics. 58: 650-6. PMID 12230000 DOI: 10.1111/J.0006-341X.2002.00650.X |
0.584 |
|
| 2002 |
Drobyski WR, Komorowski R, Logan B, Gendelman M. Role of the passive apoptotic pathway in graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 169: 1626-33. PMID 12133993 DOI: 10.4049/Jimmunol.169.3.1626 |
0.414 |
|
| 2002 |
Tamhane AC, Logan BR. Multiple test procedures for identifying the minimum effective and maximum safe doses of a drug Journal of the American Statistical Association. 97: 293-301. DOI: 10.1198/016214502753479428 |
0.579 |
|
| 2001 |
Logan BR, Tamhane AC. Combining global and marginal tests to compare two treatments on multiple endpoints Biometrical Journal. 43: 591-604. DOI: 10.1002/1521-4036(200109)43:5<591::Aid-Bimj591>3.0.Co;2-F |
0.595 |
|
| Show low-probability matches. |